According to a new study published in the CHEST, a peer-reviewed journal of the American College of Chest Physicians (ACCP), patients with COPD (Chronic obstructive pulmonary disease) who use inhaled corticosteroids are believed to have a decreased mortality risk.

Christine Macie, MD, FCCP, Cambridge Hospital, Ontario, Canada and author of this study, remarked that the survival is longer in COPD patients who make use of inhaled corticosteroids.

From Bio-medicine.org:

“Our results indicate that the effect of inhaled corticosteroids is relatively short-term and that those currently using it are relatively better protected, ” said Dr. Macie. “Inhaled corticosteroids should be prescribed as soon as clinically indicated. By treating COPD with inhaled corticosteroids, we have the potential to reduce the effect and prolong life.”

“The findings from this study are intriguing for clinicians and point to the need for further research to define the role and mechanisms of the effect of inhaled corticosteroids on both cardiovascular and respiratory mortality,” said W. Michael Alberts, MD, FCCP, President of the ACCP.

Dr. Macie also remarked that patients who are using inhaled corticosteroids are relatively better protected than those not using it.

It was found during the study that patients receiving inhaled corticosteroids within thirty days of discharge from the hospital had a 25% reduced all-cause mortality rate. Furthermore, cardiovascular related deaths were reduced by as much as 38% in patients using corticosteroids paired with beta-agonists.

Tags: chronic obstructive pulmonary disease, COPD, decreased mortality risk, inhaled corticosteroids

Posted in buy steroids, Steroid Cycles, steroid nation